29493-77-4 ((2-Oxazolamine,4,5-dihydro-4-methyl-5-phenyl-, (4R,5S)-rel-)

2-Oxazolamine,4,5-dihydro-4-methyl-5-phenyl-, (4R,5S)-rel-;CIS-(+/-)-4-METHYLAMINOREX;4-methyl-5-phenyl-2-amino-oxazoline;4-methyl-aminorex;4r-methyl-5c-phenyl-4,5-dihydro-oxazol-2-ylamine;dl-cis-2-Imino-4-methyl-5-phenyloxazolidin;(+/-)-cis-MCN-822;Oxazolidine, 1-imino-4-methyl-5-phenyl- (Z)-(-)-;CAS-29493-77-4;2149QZM652;2-Oxazolamine, 4,5-dihydro-4-methyl-5-phenyl-, (4R,5S)-rel-;cis-4-Methylaminorex;SCHEMBL10385712;Tox21_112818;McN-822;(4S,5R)-4-Methylaminorex;J5G5N6R0TM;(+/-)cis-4-methylaminorex;75493-87-7;2-Oxazolamine, 4,5-dihydro-4-methyl-5-phenyl-, cis-(+/-)-;(+/-)-cis-4-Methylaminorex;4-methylaminorex, (4S,5R)-;CHEMBL4781888;UNII-2149QZM652;DTXCID101349408;((+/-)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);(-)-cis-1-Imino-4-methyl-5-phenyloxazolidine;U4EuH;cis-(.+/-.)-4-Methylaminorex;29493-77-4;2-Oxazoline, 2-amino-4-methyl-5-phenyl-, cis-(+/-)-;DEA No. 1590;DTXSID301345890;(+/-)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline;McN-422;4-METHYLAMINOREX, (4S-CIS)-;4-Methylaminorex (cis);4-METHYLAMINOREX (CIS ISOMER);UNII-J5G5N6R0TM;NCGC00247671-01;2-Oxazolamine, 4,5-dihydro-4-methyl-5-phenyl-, (4S,5R)-;4-Methylaminorex (+/-)-cis-form [MI];LJQBMYDFWFGESC-CBAPKCEASA-N;EU4ea;4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine #;DTXSID2048870;4-Methylaminorex, cis-(+/-)-;

LJQBMYDFWFGESC-CBAPKCEASA-N

1S/C10H12N2O/c1-7-9(13-10(11)12-7)8-5-3-2-4-6-8/h2-7,9H,1H3,(H2,11,12)/t7-,9-/m0/s1

O1C(N)=N[C@@H](C)[C@H]1C1C=CC=CC=1